Conference: Personalized Medicine & Intellectual Property
Join the BU School of Law on Monday, Aug. 25, for a conference focused on personalized medicine and intellectual property.
Recently, the U.S. Supreme Court ruled in Myriad that a human gene implicated in breast and ovarian cancer was not patentable subject matter. In Prometheus, the Court also recently ruled that a method for optimizing certain drug therapies was not patentable subject matter.
BU School of Law will host a conference to examine the potential impact of these rulings on medical research. The Kauffman Foundation will fund the conference, which will bring together legal, business, medical, and economic experts to discuss the impact of these cases, and generally the impact of patent and trade secret law on the incentives for innovation in the field of personalized medicine.
When: Monday, August 25, 2014; 9:00 a.m. – 5:00 p.m.
Where: Boston University School of Law
Sumner M. Redstone Building
765 Commonwealth Avenue
Boston, MA 02215
R.S.V.P.: Register by email.
For more information and a list of speakers, visit the BU Law website.